Korea Biomedical Review
Company Information
Korea Biomedical Review
1 contacts available
Sign in to add to cart and unlock contacts.
Description
Korea Biomedical Review (KBR) is a pioneering online English newspaper dedicated to disseminating key healthcare news from Korea to a global audience. Established in February 2017, KBR operates under the umbrella of The Korean Doctors Weekly, a respected media company founded by a network of Korean doctors in 1992, renowned for its influential position in the healthcare media industry.
Delivering critical information to professionals, scholars, policymakers, and business individuals, KBR focuses on the rapidly evolving sectors of pharmaceuticals, biotechnology, and digital health in Korea. The company's primary offering is its reliable and timely news service, which has cemented KBR's place as a trusted source of healthcare news within the industry.
Aside from its primary news service, The Korean Doctors Weekly extends its influence through the publication of newspapers and over 100 healthcare books, as well as a 30-minute audio program aired seven times a week. These diverse offerings uniquely position the company as a holistic provider of healthcare information.
With a distinguished 30-year history, KBR and The Korean Doctors Weekly stand as a testament to their commitment to delivering accurate, insightful, and essential healthcare news and information, fostering a well-informed global community of healthcare professionals and enthusiasts.